Vervoort G - Search Results

1

Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease.

van Zuilen AD, Blankestijn PJ, van Buren M, Ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming L, Bots ML, Wetzels JF. van Zuilen AD, et al. Among authors: vervoort g. Neth J Med. 2011 May;69(5):229-36. Neth J Med. 2011. PMID: 21646672 Free article. Clinical Trial.

2

Nurse practitioners improve quality of care in chronic kidney disease: two-year results of a randomised study.

van Zuilen AD, Blankestijn PJ, van Buren M, ten Dam MA, Kaasjager KA, Ligtenberg G, Sijpkens YW, Sluiter HE, van de Ven PJ, Vervoort G, Vleming L, Bots ML, Wetzels JF. van Zuilen AD, et al. Among authors: vervoort g. Neth J Med. 2011 Nov-Dec;69(11):517-26. Neth J Med. 2011. PMID: 22173365 Free article. Clinical Trial.

3

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.

Vervloet MG, van Zuilen AD, Heijboer AC, ter Wee PM, Bots ML, Blankestijn PJ, Wetzels JF; MASTERPLAN group study. Vervloet MG, et al. BMC Nephrol. 2012 Apr 24;13:20. doi: 10.1186/1471-2369-13-20. BMC Nephrol. 2012. PMID: 22530966 Free PMC article.

4

Progressive renal disease despite immunosuppressive therapy in a patient with Wegener s granulomatosis.

Klein I, Vervoort G, Steenbergen E, Wetzels J. Klein I, et al. Among authors: vervoort g. Neth J Med. 2008 Mar;66(3):125-7. Neth J Med. 2008. PMID: 18349469 Free article.

5

[Hyponatremia: effective treatment based on calculated outcomes].

Vervoort G, Wetzels JF. Vervoort G, et al. Ned Tijdschr Geneeskd. 2006 Sep 30;150(39):2121-6. Ned Tijdschr Geneeskd. 2006. PMID: 17059083 Dutch.

6

The impact of blood pressure measurement methods on the assessment of differences in blood pressure levels between patients with normoalbuminuric type 1 diabetes and healthy controls.

Vervoort G, Wetzels JF, Lutterman JA, Berden JH, Thien T, Smits P. Vervoort G, et al. J Hum Hypertens. 1999 Feb;13(2):117-22. doi: 10.1038/sj.jhh.1000776. J Hum Hypertens. 1999. PMID: 10100060 Clinical Trial.

7

[Renal function assessment].

Vervoort G, Wetzels JF. Vervoort G, et al. Ned Tijdschr Geneeskd. 2007 Aug 4;151(31):1753; author reply 1753-4. Ned Tijdschr Geneeskd. 2007. PMID: 17784701 Dutch. No abstract available.

8

Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.

Vervoort G, Hertenberg F, Wetzels JF, Smits P. Vervoort G, et al. J Hypertens. 1998 Feb;16(2):245-50. doi: 10.1097/00004872-199816020-00016. J Hypertens. 1998. PMID: 9535153 Clinical Trial.

9

Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion.

Vervoort G, Veldman B, Berden JH, Smits P, Wetzels JF. Vervoort G, et al. Eur J Clin Invest. 2005 May;35(5):330-6. doi: 10.1111/j.1365-2362.2005.01497.x. Eur J Clin Invest. 2005. PMID: 15860045

10

Low concentrations of intravenous polygelines promote low-molecular weight proteinuria.

Veldman BA, Schepkens HL, Vervoort G, Klasen I, Wetzels JF. Veldman BA, et al. Among authors: vervoort g. Eur J Clin Invest. 2003 Nov;33(11):962-8. doi: 10.1046/j.1365-2362.2003.01258.x. Eur J Clin Invest. 2003. PMID: 14636299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters